-
NCarrillo replied to the topic "Are We Over-Relying on FMEAs?" – 17 hours, 3 minutes ago
FMEAs are indeed a useful tool for evaluating the types of failures a system could experience if one (or several) of its components fail. This is especially true for medical devices, which include various components/subsystems that, when under the right… Read more»
-
NCarrillo replied to the topic "Risk Acceptance" – 2 days, 17 hours ago
I believe risk acceptance and its effect(s) are directly tied to the quality of the risk assessment itself, which also affects the form of a response to the hazard. When risk assessment is conducted, there is an order of precedence… Read more»
-
NCarrillo replied to the topic "Hazard, Hazardous, Harm" – 3 days, 14 hours ago
During my time as a co-op at GAF, I have witnessed a variety of hazards that had to be mitigated, mostly within the R&D labs. Each of the labs had a variety of equipment with varying levels of risk. One… Read more»
-
NCarrillo replied to the topic "How Many Design Reviews Are Enough?" – 1 week ago
@shreya This is a great set of ideas to build upon for the complexities of developing & reviewing a potential product, especially regarding living documents, progress traceability & structure. I want to add my thoughts on using these methods. When… Read more»
-
NCarrillo replied to the topic "Verification vs. Validation — Do We Really Need Both?" – 1 week, 2 days ago
Both processes are necessary to ensure the product pleases two key stakeholders: the company itself and its customers. Maintaining this distinct difference between them enables specialized processes that cater to the target audience(s). Putting it together would unlikely be effective…. Read more»
-
NCarrillo replied to the topic "Efficiency or Compliance?" – 1 week, 4 days ago
Ideally, you’d imagine companies doing both. They need to fulfill regulatory requirements for the sake of remaining compliant, but they must strive to uphold product quality to maintain or improve their market share. This is especially true when considering all… Read more»
-
NCarrillo replied to the topic "Impact of customer feedback on design inputs" – 2 weeks, 1 day ago
Design teams, from my experience, tend to prioritize the most realistic aspects of a design. The end goal is to meet the customer’s requirements, yes, but at the same time, they cannot expect us to produce certain extraneous features that… Read more»
-
NCarrillo replied to the topic "Bridging the Gap Between Users Needs and Design Inputs" – 2 weeks, 1 day ago
Hi Jacob, you’ve provided a great definition of what makes an effective design input. There’s actually a mechanism that Dr. Simon discussed this week in the lecture. To turn a qualitative design goal into a quantitative result, you need to… Read more»
-
NCarrillo replied to the topic "Minutes for meetings" – 2 weeks, 3 days ago
Meeting minutes are a useful tool for logging significant portions of a meeting, especially when discussing subjects such as design reviews/controls. This gives professionals the ability to keep tabs on a project’s progress through crucial milestones and data, especially during… Read more»
-
NCarrillo posted a new topic "The Placebo vs. The Nocebo Effect in Blind Clinical Studies" – 3 weeks, 1 day ago
When discussing the placebo effect in a blind/double blind study and how it provides a neutral control for researchers to determine how well their drug performs, we focus on the assumptions that patients are making and how that psychological response… Read more»
-
NCarrillo replied to the topic "Placebo Effect" – 3 weeks, 2 days ago
Unlike a good portion of the responses here, I believe the placebo effect is a reliable way to keep patients and researchers from having implicit expectations relating to the response to the given drug sample. It yields more accurate data… Read more»
-
NCarrillo liked forum post "Placebo Effect" – 3 weeks, 2 days ago
-
NCarrillo replied to the topic "Clinical Trial Participation" – 3 weeks, 3 days ago
Patients participating in a study should generally be compensated in some form, including financially. This is dependent on several factors, namely the phase of the study and the severity of the preexisting condition(s) they have been selected for. For… Read more»
-
NCarrillo replied to the topic "Transition from Engineering to sales or marketing?" – 1 month ago
As I’ve worked closely with designers, manufacturers, and everyone in between during my short time in the industry, I’ve gained much understanding of how a product should be developed based on market needs, statistical trends, and limitations. Thus, I’d likely… Read more»
-
NCarrillo replied to the topic "Should We Trust AI With the Future of Medical Device Marketing?" – 1 month ago
The ethical value of AI can be twofold. On one hand, it’s a powerful resource that will help researchers & even designers compile a large chunk of pertinent information in a shorter period of time than it would take with… Read more»
-
NCarrillo replied to the topic "Should Patients Be Involved in Marketing Strategies?" – 1 month ago
Patients should definitely have a say in the design of their products for companies. As they are the end users for the products intended to solve or at least mitigate their ailment(s), they can discuss what they enjoy most about… Read more»
- Load More